Bastyr University, Seattle, Washington, United States of America.
PLoS One. 2009 Dec 18;4(12):e8271. doi: 10.1371/journal.pone.0008271.
PK 11195 and DAA1106 bind with high-affinity to the translocator protein (TSPO, formerly known as the peripheral benzodiazepine receptor). TSPO expression in glial cells increases in response to cytokines and pathological stimuli. Accordingly, [(11)C]-PK 11195 and [(11)C]-DAA1106 are recognized molecular imaging (MI) agents capable of monitoring changes in TSPO expression occurring in vivo and in response to various neuropathologies.Here we tested the pharmacological characteristics and TSPO-monitoring potential of two novel MI agents: NIR-conPK and NIR-6T. NIR-conPK is an analogue of PK 11195 conjugated to the near-infrared (NIR) emitting fluorophore: IRDye 800CW. NIR-6T is a DAA1106 analogue also conjugated to IRDye 800CW.We found that NIR-6T competed for [(3)H]-PK 11195 binding in astrocytoma cell homogenates with nanomolar affinity, but did not exhibit specific binding in intact astrocytoma cells in culture, indicating that NIR-6T is unlikely to constitute a useful MI agent for monitoring TSPO expression in intact cells. Conversely, we found that NIR-conPK did not compete for [(3)H]-PK 11195 binding in astrocytoma cell homogenate, but exhibited specific binding in intact astrocytoma cells in culture with nanomolar affinity, suggesting that NIR-conPK binds to a protein distinct, but related to, TSPO. Accordingly, treating intact astrocytoma cells and microglia in culture with cytokines led to significant changes in the amount of NIR-conPK specific binding without corresponding change in TSPO expression. Remarkably, the cytokine-induced changes in the protein targeted by NIR-conPK in intact microglia were selective, since IFN-gamma (but not TNFalpha and TGFbeta) increased the amount of NIR-conPK specific binding in these cells.Together these results suggest that NIR-conPK binds to a protein that is related to TSPO, and expressed by astrocytomas and microglia. Our results also suggest that the expression of this protein is increased by specific cytokines, and thus allows for the monitoring of a particular subtype of microglia activation.
PK 11195 和 DAA1106 与转位蛋白(TSPO,以前称为外周苯二氮䓬受体)高亲和力结合。胶质细胞中的 TSPO 表达会响应细胞因子和病理刺激而增加。因此,[(11)C]-PK 11195 和 [(11)C]-DAA1106 被认为是能够监测体内 TSPO 表达变化的分子成像(MI)剂,以及对各种神经病理学的反应。在这里,我们测试了两种新型 MI 剂:NIR-conPK 和 NIR-6T 的药理学特性和 TSPO 监测潜力。NIR-conPK 是 PK 11195 的类似物,与近红外(NIR)发射荧光团:IRDye 800CW 缀合。NIR-6T 是 DAA1106 的类似物,也与 IRDye 800CW 缀合。我们发现 NIR-6T 以纳摩尔亲和力与星形细胞瘤细胞匀浆中的 [(3)H]-PK 11195 结合竞争,但在培养的完整星形细胞瘤细胞中没有表现出特异性结合,表明 NIR-6T 不太可能成为监测完整细胞中 TSPO 表达的有用 MI 剂。相反,我们发现 NIR-conPK 不会与星形细胞瘤细胞匀浆中的 [(3)H]-PK 11195 结合竞争,但以纳摩尔亲和力在培养的完整星形细胞瘤细胞中表现出特异性结合,表明 NIR-conPK 与 TSPO 不同但相关的蛋白结合。因此,用细胞因子处理培养的完整星形细胞瘤细胞和小胶质细胞会导致 NIR-conPK 特异性结合的量发生显著变化,而 TSPO 表达没有相应变化。值得注意的是,NIR-conPK 在完整小胶质细胞中靶向的蛋白的细胞因子诱导变化是选择性的,因为 IFN-γ(而非 TNFalpha 和 TGFbeta)增加了这些细胞中 NIR-conPK 特异性结合的量。这些结果表明,NIR-conPK 与 TSPO 相关的蛋白结合,并由星形细胞瘤和小胶质细胞表达。我们的结果还表明,这种蛋白的表达会被特定的细胞因子增加,因此可以监测特定类型的小胶质细胞激活。